Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects
Clinical trial NCT03141658 · COMPLETED
Trial details
- NCT number
- NCT03141658
- Sponsor
- Taisho Pharmaceutical R&D Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2018-04-04
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.